ATAI is a global biotech company builder that leverages a decentralized, technology-and-data-driven platform model to serve millions of people suffering with mental health disorders.
They are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space.
By pooling expertise, best practices, and resources across our entire portfolio, ATAI mitigates risk and responsibly accelerates the development of impactful and evidence-based therapies.
.png)
